On the public citation graph
Multidimensional comprehensive and integrated analysis of the potential function of TMEM25 in renal clear cell carcinoma with low expression status
0 signed · 54 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
1 of the 50 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-11): 10.1186/s13046-021-01889-8 (notice 2023-06-06).
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.ajhg.2012.05.002openalex-snapshot
TMEM165 Deficiency Causes a Congenital Disorder of Glycosylation
inferredcites →https://doi.org/10.1016/j.biopha.2018.05.016openalex-snapshot
Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer
inferredcites →https://doi.org/10.1016/j.ctrv.2014.12.013openalex-snapshot
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
inferredcites →https://doi.org/10.1016/j.ctrv.2018.07.009openalex-snapshot
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1016/j.ctrv.2021.102157openalex-snapshot
Finding predictive factors for immunotherapy in metastatic renal-cell carcinoma: What are we looking for?
inferredcites →https://doi.org/10.1016/j.ejca.2008.10.023openalex-snapshot
Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients
inferredcites →https://doi.org/10.1016/j.juro.2009.12.035openalex-snapshot
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.pharmthera.2016.09.011openalex-snapshot
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
inferredcites →https://doi.org/10.1016/j.tig.2021.05.002openalex-snapshot
Navigating the DNA methylation landscape of cancer
inferredcites →https://doi.org/10.1016/s1470-2045(22)00290-xopenalex-snapshot
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
inferredcites →https://doi.org/10.1038/nature12222openalex-snapshot
Comprehensive molecular characterization of clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1038/ng.2323openalex-snapshot
BAP1 loss defines a new class of renal cell carcinoma
inferredcites →https://doi.org/10.1038/ni.2703openalex-snapshot
Innate and adaptive immune cells in the tumor microenvironment
inferredcites →https://doi.org/10.1038/s41388-020-1234-3openalex-snapshot
Modeling clear cell renal cell carcinoma and therapeutic implications
inferredcites →https://doi.org/10.1038/s41419-021-04369-1openalex-snapshot
TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway
inferredcites →https://doi.org/10.1038/s41467-021-25865-0openalex-snapshot
Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
inferredcites →https://doi.org/10.1038/s41581-020-00359-2openalex-snapshot
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
inferredcites →https://doi.org/10.1038/s41585-019-0211-5openalex-snapshot
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
inferredcites →https://doi.org/10.1038/s41591-018-0053-3openalex-snapshot
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
inferredcites →https://doi.org/10.1056/nejmoa1303989openalex-snapshot
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
inferredcites →https://doi.org/10.1093/ajcp/aqaa176openalex-snapshot
BAP1-Mutated Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1093/nar/27.3.839openalex-snapshot
Identification of differentially expressed mRNAs in human fetal liver across gestation
inferredcites →https://doi.org/10.1093/nar/gks1193openalex-snapshot
NCBI GEO: archive for functional genomics data sets—update
inferredcites →https://doi.org/10.1111/j.1349-7006.2011.01945.xopenalex-snapshot
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1111/jvh.12265openalex-snapshot
PCDH 20 functions as a tumour‐suppressor gene through antagonizing the W nt/β‐catenin signalling pathway in hepatocellular carcinoma
inferredcites →https://doi.org/10.1126/sciadv.abh2169openalex-snapshot
A single–cell type transcriptomics map of human tissues
inferredcites →https://doi.org/10.1126/science.aab4082openalex-snapshot
Somatic mutation in cancer and normal cells
inferredcites →https://doi.org/10.1126/science.aan5951openalex-snapshot
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1136/jitc-2020-000552openalex-snapshot
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1158/0008-5472.can-15-3278openalex-snapshot
DNA Methylation in Cancer and Aging
inferredcites →https://doi.org/10.1158/1535-7163.mct-17-1299openalex-snapshot
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
inferredcites →https://doi.org/10.1159/000239795openalex-snapshot
TMEM25, REPS2 and Meis 1: Favourable Prognostic and Predictive Biomarkers for Breast Cancer
inferredcites →https://doi.org/10.1186/1471-2490-14-14openalex-snapshot
ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1186/s12885-015-1530-4openalex-snapshot
Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
inferredcites →https://doi.org/10.1186/s12885-021-08046-6openalex-snapshot
High Expression of TMEM180, a Novel Tumour Marker, Is Associated with Poor Survival in Stage III Colorectal Cancer
inferredcites →https://doi.org/10.1186/s13046-021-01889-8openalex-snapshot
RETRACTED ARTICLE: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
inferredcites →https://doi.org/10.1186/s13046-021-01969-9openalex-snapshot
Correction to: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
inferredcites →https://doi.org/10.1371/journal.pone.0057886openalex-snapshot
Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States
inferredcites →https://doi.org/10.14712/18059694.2017.84openalex-snapshot
Phenotype Analysis of Tumour-infiltrating Lymphocytes and Lymphocytes in Peripheral Blood in Patients with Renal Carcinoma
inferredcites →https://doi.org/10.2174/157489213805290556openalex-snapshot
The Use of Cytokines and Chemokines in the Cancer Immunotherapy
inferredcites →https://doi.org/10.3233/dma-120948openalex-snapshot
TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.
inferredcites →https://doi.org/10.3389/fgene.2020.575776openalex-snapshot
TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3389/fonc.2021.814396openalex-snapshot
Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.3727/096504016x14821477992177openalex-snapshot
Silencing Transmembrane Protein 45B (TNEM45B) Inhibits Proliferation, Invasion, and Tumorigenesis in Osteosarcoma Cells
inferredcites →https://doi.org/10.3785/j.issn.1008-9292.2017.08.04openalex-snapshot
[Effects of lncRNA RP11-770J1.3 and TMEM25 expression on paclitaxel resistance in human breast cancer cells].
inferredcites →https://doi.org/10.3892/or.12.2.429openalex-snapshot
Identification and characterization of human TMEM25 and mouse Tmem25 genes in silico
inferredcites →https://doi.org/10.7150/ijbs.71519openalex-snapshot
Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma
inferredcites →https://doi.org/10.7150/ijbs.74647openalex-snapshot
Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4888096openalex-extracted
Multi-Omics Reveals Tumor Cell Heterogeneity Effects on the Immunosuppression in ccRCC and Facilitates Prognostic Model Construction
inferred← citeshttps://doi.org/10.1159/000548124openalex-snapshot
Machine Learning-Based Prognostic Modeling of Seven Signatures Associated with Lysosomes for Predicting Prognosis and Immune Status in Clear Cell Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.26599/bdma.2024.9020039openalex-snapshot
A Comprehensive Investigation to Identify Prognostic mRNA and miRNA Signatures for Renal Cell Carcinoma Utilizing a Stratification-Based Approach
inferred← citeshttps://doi.org/10.31083/j.fbl2908285openalex-snapshot
TMEM17 Promotes Tumor Progression in Glioblastoma by Activating the PI3K/AKT Pathway
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.